Skip to content
HyperClubOnline offers expert fitness advice, nutrition gui…

Patients Coming Off Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Compared to Dieters

Image of medical injection and weighing machine
Obesity treatment often requires long-term strategies.

New research indicates that patients who come off popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt conventional lifestyle regimens.

Published data in a prominent health publication shows that while obese individuals often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month once they quit.

"People buying these drugs need to be cognizant of the risk of rapid weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.

Such speed of regain suggests a return to pre-treatment mass within about a year and a half.

Analyzing Approaches

The study, which looked at 37 of trials involving over 9,000 of participants, compared the outcomes of these new drugs with other pills.

The team point out that individuals who shed pounds through diet and exercise usually have a more gradual creep back—approximately 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Experts believe the mechanism of the drugs accounts for the accelerated rebound.

These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.

"Long-term administration of the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely."

A Chronic Condition?

The NHS suggest the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes.

Many experts argue that, given the high risk of weight regain, the treatment should be considered life-long.

This view is echoed by drug manufacturers, who say that the results "underscore the persistent nature of excess weight," similar to managing conditions like high blood pressure.

Patient Experiences

People who have stopped the medication report a powerful return of appetite.

"It felt as if something that goes on and I was suddenly ravenous," recalled one woman.

The struggle is worsened if patients have not developed sustainable lifestyle or habit modifications during treatment.

Widespread Use

Survey data suggest that millions of people in the UK have used weight-loss jabs in the past year, with desire remaining high.

  • Use is greater among women compared to men.
  • The 40s and 50s demographic shows the highest usage rates.
  • Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a magic fix and lasting health benefits hinges on integrated behavioural changes.

About the author

Hunter Watts

Certified personal trainer and nutritionist with over 8 years of experience in holistic wellness coaching.

HyperClubOnline

Type to search articles.